Updates in the management of congenital heart disease in adult patients

References

• Khairy P, Van Hare GF, Balaji S, et al. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm. 2014 Oct;11(10):e102–65.
   PubMedGoogle Scholar
• Bouchardy J, Therrien J, Pilote L, et al. Atrial arrhythmias in adults with congenital heart disease. Circulation. 2009 Oct 27 120(17):1679–1686.
   PubMed Web of Science ®Google Scholar
• Ghonim S, Gatzoulis MA, Ernst S, et al. Predicting survival in repaired tetralogy of fallot: a lesion-specific and personalized approach. JACC Cardiovasc Imaging. 2022 Feb;15(2):257–268.
   PubMed Web of Science ®Google Scholar
• Khairy P, Dore A, Poirier N, et al. Risk stratification in surgically repaired tetralogy of Fallot. Expert Rev Cardiovasc Ther. 2009 Jul;7(7):755–762.
   PubMedGoogle Scholar
• Khairy P, Harris L, Landzberg MJ, et al. Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study. Circ Arrhythm Electrophysiol. 2008 Oct;1(4):250–257.
   PubMed Web of Science ®Google Scholar
• Lewis MJ, Van Dissel A, Kochav J, et al. Cardiac MRI predictors of adverse outcomes in adults with a systemic right ventricle. ESC Heart Fail. 2022 Apr;9(2):834–841.
   PubMed Web of Science ®Google Scholar
• Ross HJ, Law Y, Book WM, et al. Transplantation and mechanical circulatory support in congenital heart disease: a scientific statement from the American Heart Association. Circulation (New York, NY). 2016;133(8): 802–820
   Google Scholar
• Stout KK, Daniels CJ, Aboulhosn JA, et al. AHA/ACC Guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 2018 [2019 Apr 2];139(14):e698–e800.
   Web of Science ®Google Scholar
• Egidy Assenza G, Krieger EV, Baumgartner H, et al. AHA/ACC vs ESC guidelines for management of adults with congenital heart disease: jacc guideline comparison. J Am Coll Cardiol. 2021 Nov 9;78(19):1904–1918.
   PubMed Web of Science ®Google Scholar
• Baumgartner H, De Backer J, Babu-Narayan SV, et al. ESC Guidelines for the management of adult congenital heart disease: the Task Force for the management of adult congenital heart disease of the European Society of Cardiology (ESC). Endorsed by: association for European Paediatric and Congenital Cardiology (AEPC), International Society for Adult Congenital Heart Disease (ISACHD). Eur Heart J. 2020;42(6):563–645.
   Google Scholar
• Loomba RS, Buelow MW, Aggarwal S, et al. Arrhythmias in adults with congenital heart disease: what are risk factors for specific arrhythmias? Pacing Clin Electrophysiol. 2017 Apr;40(4):353–361.
   PubMed Web of Science ®Google Scholar
• Khairy P, Clair M, Fernandes SM, et al. Cardiovascular outcomes after the arterial switch operation for D-transposition of the great arteries. Circulation. 2013 Jan 22 127(3):331–339.
   PubMed Web of Science ®Google Scholar
• Khairy P. Arrhythmias in adults with congenital heart disease: what the practicing cardiologist needs to know. Can J Cardiol. 2019 Dec;35(12):1698–1707.
   PubMed Web of Science ®Google Scholar
• Kawada S, Chakraborty P, Roche L, et al. Role of amiodarone in the management of atrial arrhythmias in adult Fontan patients. Heart. 2020 Oct 28
   Web of Science ®Google Scholar
• Roy K, Gomez-Pulido F, Ernst S. Remote magnetic navigation for catheter ablation in patients with congenital heart disease: a review. J Cardiovasc Electrophysiol. 2016 Mar;27(1):S45–56.
   PubMedGoogle Scholar
• Betts TR, Roberts PR, Allen SA, et al. Electrophysiological mapping and ablation of intra-atrial reentry tachycardia after Fontan surgery with the use of a noncontact mapping system. Circulation. 2000 Jul 25;102(4):419–425.
   PubMed Web of Science ®Google Scholar
• Chiu MH, Mitchell LB, Ploquin N, et al. Review of stereotactic arrhythmia radioablation therapy for cardiac tachydysrhythmias. CJC Open. 2021 Mar;3(3):236–247
   PubMedGoogle Scholar
• Wei C, Qian P, Tedrow U, et al. Non-invasive stereotactic radioablation: a new option for the treatment of ventricular arrhythmias. Arrhythm Electrophysiol Rev. 2020 Feb 12 8(4):285–293.
   PubMed Web of Science ®Google Scholar
• Kolandaivelu A, Lardo AC, Halperin HR. Cardiovascular magnetic resonance guided electrophysiology studies. J Cardiovasc Magn Reson. 2009 Jul 6; 11(1):21.
   PubMedGoogle Scholar
• Chubb H, Williams SE, Whitaker J, et al. Cardiac electrophysiology under MRI guidance: an emerging technology. Arrhythm Electrophysiol Rev. 2017 Jun;6(2):85–93.
   PubMed Web of Science ®Google Scholar
• Le Bloa M, Abadir S, Nair K, et al. New developments in catheter ablation for patients with congenital heart disease. Expert Rev Cardiovasc Ther. 2021 Jan;19(1):15–26.
   PubMed Web of Science ®Google Scholar
• Suman-Horduna I, Babu-Narayan SV, Ueda A, et al. Magnetic navigation in adults with atrial isomerism (heterotaxy syndrome) and supraventricular arrhythmias. Europace. 2013 Jun;15(6):877–885.
   PubMed Web of Science ®Google Scholar
• Ernst S, Babu-Narayan SV, Keegan J, et al. Remote-controlled magnetic navigation and ablation with 3D image integration as an alternative approach in patients with intra-atrial baffle anatomy. Circ Arrhythm Electrophysiol. 2012 Feb;5(1):131–139.
   PubMed Web of Science ®Google Scholar
• Roudijk RW, Gujic M, Suman-Horduna I, et al. Catheter ablation in children and young adults: is there an additional benefit from remote magnetic navigation? Neth Heart J. 2013 Jun;21(6):296–303.
   PubMed Web of Science ®Google Scholar
• Silka MJ, Hardy BG, Menashe VD, et al. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol. 1998 Jul;32(1):245–251.
   PubMed Web of Science ®Google Scholar
• Khairy P, Silka MJ, Moore JP, et al. Sudden cardiac death in congenital heart disease. Eur Heart J. 2022 Mar 18;43(22):2103–2115.
   PubMed Web of Science ®Google Scholar
• Khairy P, Landzberg MJ, Gatzoulis MA, et al. Value of programmed ventricular stimulation after tetralogy of fallot repair: a multicenter study. Circulation. 2004 Apr 27 109(16):1994–2000
   PubMed Web of Science ®Google Scholar
• Khairy P, Harris L, Landzberg MJ, et al. Implantable cardioverter-defibrillators in tetralogy of fallot. Circulation. 2008 Jan 22;117(3):363–370.
   PubMed Web of Science ®Google Scholar
• Lynge TH, Jeppesen AG, Winkel BG, et al. Nationwide study of sudden cardiac death in people with congenital heart defects aged 0 to 35 years. Circ Arrhythm Electrophysiol. 2018 Jun;11(6):e005757.
   PubMed Web of Science ®Google Scholar
• Moore B, Yu C, Kotchetkova I, et al. Incidence and clinical characteristics of sudden cardiac death in adult congenital heart disease. Int J Cardiol. 2018 Mar 1;254:101–106.
   PubMed Web of Science ®Google Scholar
• Gallego P, Gonzalez AE, Sanchez-Recalde A, et al. Incidence and predictors of sudden cardiac arrest in adults with congenital heart defects repaired before adult life. Am J Cardiol. 2012 Jul 1 110(1):109–117.
   PubMed Web of Science ®Google Scholar
• van der Velde ET, Vriend JW, Mannens MM, et al. CONCOR, an initiative towards a national registry and DNA-bank of patients with congenital heart disease in the Netherlands: rationale, design, and first results. Eur J Epidemiol. 2005;20(6):549–557.
   PubMed Web of Science ®Google Scholar
• Silka MJ, Bar-Cohen Y. A contemporary assessment of the risk for sudden cardiac death in patients with congenital heart disease. Pediatr Cardiol. 2012 Mar;33(3):452–460.
   PubMed Web of Science ®Google Scholar
• Diller GP, Kempny A, Alonso-Gonzalez R, et al. Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre. Circulation. 2015 Dec 1 132(22):2118–2125.
   PubMed Web of Science ®Google Scholar
• Raissadati A, Nieminen H, Haukka J, et al. Late causes of death after pediatric cardiac surgery: a 60-year population-based study. J Am Coll Cardiol. 2016 Aug 2 68(5):487–498.
   PubMed Web of Science ®Google Scholar
• Oliver JM, Gallego P, Gonzalez AE, et al. Predicting sudden cardiac death in adults with congenital heart disease. Heart. 2021 Jan;107(1):67–75.
   PubMed Web of Science ®Google Scholar
• Zormpas C, Silber‐Peest AS, Eiringhaus J, et al. Eligibility for subcutaneous implantable cardioverter‐defibrillator in adults with congenital heart disease. ESC Heart Fail. 2021;8(2):1502–1508.
   PubMed Web of Science ®Google Scholar
• Atallah J, Gonzalez Corcia MC, Walsh EP, et al. Ventricular arrhythmia and life-threatening events in patients with repaired tetralogy of fallot. Am J Cardiol. 2020 Oct 1;132:126–132.
   PubMed Web of Science ®Google Scholar
• Possner M, Tseng SY, Alahdab F, et al. Risk factors for mortality and ventricular tachycardia in patients with repaired tetralogy of fallot: a systematic review and meta-analysis. Can J Cardiol. 2020 Nov;36(11):1815–1825.
   PubMed Web of Science ®Google Scholar
• Cohen MI, Khairy P, Zeppenfeld K, et al. Preventing arrhythmic death in patients with tetralogy of fallot. J Am Coll Cardiol. 2021 Feb 16;77(6):761–771.
   PubMed Web of Science ®Google Scholar
• Geva T, Mulder B, Gauvreau K, et al. Preoperative predictors of death and sustained ventricular tachycardia after pulmonary valve replacement in patients with repaired tetralogy of fallot enrolled in the INDICATOR Cohort. Circulation. 2018 Nov 6 138(19):2106–2115.
   PubMed Web of Science ®Google Scholar
• Sabate Rotes A, Connolly HM, Warnes CA, et al. Ventricular arrhythmia risk stratification in patients with tetralogy of Fallot at the time of pulmonary valve replacement. Circ Arrhythm Electrophysiol. 2015 Feb;8(1):110–116.
   PubMed Web of Science ®Google Scholar
• Kariki O, Antoniou C-K, Mavrogeni S, et al. Updating the risk stratification for sudden cardiac death in cardiomyopathies: the evolving role of cardiac magnetic resonance imaging an approach for the electrophysiologist. Diagnostics. 2020;10(8).
   Web of Science ®Google Scholar
• Gatzoulis KA, Archontakis S, Dilaveris P, et al. Ventricular arrhythmias: from the electrophysiology laboratory to clinical practice. Part II: potentially malignant and benign ventricular arrhythmias. Hellenic J Cardiol. 2012 May-Jun;53(3):217–233.
   PubMed Web of Science ®Google Scholar
• Arsenos P, Gatzoulis KA, Tsiachris D, et al. Arrhythmic risk stratification in ischemic, non-ischemic and hypertrophic cardiomyopathy: a two-step multifactorial, electrophysiology study inclusive approach. World J Cardiol. 2022 Mar 26 14(3):139–151.
   PubMed Web of Science ®Google Scholar
• Heng EL, Bolger AP, Kempny A, et al. Neurohormonal activation and its relation to outcomes late after repair of tetralogy of fallot. Heart. 2015 Mar;101(6):447–454.
   PubMed Web of Science ®Google Scholar
• Kalaitzidis P, Orwat S, Kempny A, et al. Biventricular dyssynchrony on cardiac magnetic resonance imaging and its correlation with myocardial deformation, ventricular function and objective exercise capacity in patients with repaired tetralogy of Fallot. Int J Cardiol. 2018 Aug 1;264:53–57.
   PubMed Web of Science ®Google Scholar
• Jing L, Wehner GJ, Suever JD, et al. Left and right ventricular dyssynchrony and strains from cardiovascular magnetic resonance feature tracking do not predict deterioration of ventricular function in patients with repaired tetralogy of Fallot. J Cardiovasc Magn Reson. 2016 Aug 22 18(1):49.
   PubMedGoogle Scholar
• Ortega M, Triedman JK, Geva T, et al. Relation of left ventricular dyssynchrony measured by cardiac magnetic resonance tissue tracking in repaired tetralogy of fallot to ventricular tachycardia and death. Am J Cardiol. 2011 May 15 107(10):1535–1540.
   PubMed Web of Science ®Google Scholar
• Moon TJ, Choueiter N, Geva T, et al. Relation of biventricular strain and dyssynchrony in repaired tetralogy of fallot measured by cardiac magnetic resonance to death and sustained ventricular tachycardia. Am J Cardiol. 2015 Mar 1 115(5):676–680.
   PubMed Web of Science ®Google Scholar
• Liu Jennifer E, Barac A, Thavendiranathan P, et al. Strain imaging in cardio-oncology. JACC: CardioOncology. 2020;2(5):677–689.
   PubMedGoogle Scholar
• van Grootel RWJ, van den Bosch AE, Baggen VJM, et al. The prognostic value of myocardial deformation in adult patients with corrected tetralogy of fallot. J Am Soc Echocardiogr. 2019 Jul;32(7):866–875 e2.
   PubMed Web of Science ®Google Scholar
• Babu-Narayan SV, Kilner PJ, Li W, et al. Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of fallot and its relationship to adverse markers of clinical outcome. Circulation. 2006 Jan 24 113(3):405–413.
   PubMed Web of Science ®Google Scholar
• Shade JK, Cartoski MJ, Nikolov P, et al. Ventricular arrhythmia risk prediction in repaired tetralogy of fallot using personalized computational cardiac models. Heart Rhythm. 2020 Mar;17(3):408–414.
   PubMed Web of Science ®Google Scholar
• Vehmeijer JT, Koyak Z, Zwinderman AH, et al. PREVENTION-ACHD: pRospEctiVE study on implaNTable cardioverter-defibrillator therapy and suddeN cardiac death in adults with congenital heart disease; rationale and design. Neth Heart J. 2019 Oct;27(10):474–479.
   PubMed Web of Science ®Google Scholar
• Vehmeijer JT, Koyak Z, Leerink JM, et al. Identification of patients at risk of sudden cardiac death in congenital heart disease: the PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease (PREVENTION-ACHD). Heart Rhythm. 2021 May;18(5):785–792.
   PubMed Web of Science ®Google Scholar
• Al-Khatib SF, Stevenson WG, Stevenson WF, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the heart rhythm society. (1558–3597 ( Electronic)).
   Google Scholar
• Gatzoulis MA, Till JA, Somerville J, et al. Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. 1995 Jul 15 92(2):231–237.
   PubMed Web of Science ®Google Scholar
• Valente AM, Gauvreau K, Assenza GE, et al. Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort. Heart. 2014 Feb;100(3):247–253.
   PubMed Web of Science ®Google Scholar
• Bokma JP, Winter MM, Vehmeijer JT, et al. QRS fragmentation is superior to QRS duration in predicting mortality in adults with tetralogy of Fallot. Heart. 2017 May;103(9):666–671.
   PubMed Web of Science ®Google Scholar
• Waldmann V, Bouzeman A, Duthoit G, et al. Long-term follow-up of patients with tetralogy of fallot and implantable cardioverter defibrillator: the DAI-T4F Nationwide Registry. Circulation. 2020 Oct 27 142(17):1612–1622.
   PubMed Web of Science ®Google Scholar
• Leusveld EM, Kauling RM, Geenen LW, et al. Heart failure in congenital heart disease: management options and clinical challenges. Expert Rev Cardiovasc Ther. 2020 Aug;18(8):503–516.
   PubMed Web of Science ®Google Scholar
• Arnaert S, De Meester P, Troost E, et al. Heart failure related to adult congenital heart disease: prevalence, outcome and risk factors. ESC Heart Fail. 2021;8(4):2940–2950.
   PubMed Web of Science ®Google Scholar
• Cedars A, Vanderpluym C, Koehl D, et al. An Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of hospitalization, functional status, and mortality after mechanical circulatory support in adults with congenital heart disease. J Heart Lung Transplant. 2018;37(5):619–630.
   PubMed Web of Science ®Google Scholar
• Diller G-P. Incidence and prevalence of heart failure in adults with congenital heart disease. In: Swan L, Frogoudaki AA, editors. Heart failure in adult congenital heart disease. Cham: Springer International Publishing; 2018. p. 3–9.
   Google Scholar
• Yu C, Moore BM, Kotchetkova I, et al. Causes of death in a contemporary adult congenital heart disease cohort. Heart. 2018 Oct;104(20):1678–1682.
   PubMed Web of Science ®Google Scholar
• Cohen S, Liu A, Wang F, et al. Risk prediction models for heart failure admissions in adults with congenital heart disease. Int J Cardiol. 2021 Jan 1;322:149–157.
   PubMed Web of Science ®Google Scholar
• Lanz J, Brophy JM, Therrien J, et al. Stroke in adults with congenital heart disease: incidence, cumulative risk, and predictors. Circulation. 2015 Dec 22 132(25):2385–2394.
   PubMed Web of Science ®Google Scholar
• Tsang W, Silversides CK, Rashid M, et al. Outcomes and healthcare resource utilization in adult congenital heart disease patients with heart failure. ESC Heart Fail. 2021;8(5):4139–4151.
   PubMed Web of Science ®Google Scholar
• Frogoudaki AA. Pathophysiology and causes of heart failure in adult congenital heart disease. In: Swan L, Frogoudaki AA, editors. Heart failure in adult congenital heart disease. Cham: Springer International Publishing; 2018. p. 11–30.
   Google Scholar
• Budts W, Roos-Hesselink J, Radle-Hurst T, et al. Treatment of heart failure in adult congenital heart disease: a position paper of the working group of grown-up congenital heart disease and the heart failure association of the European Society of Cardiology. Eur Heart J. 2016 May 7 37(18):1419–1427.
   PubMed Web of Science ®Google Scholar
• Khairy P, Van Hare GF, Balaji S, et al. PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric And Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Can J Cardiol. 2014 Oct;30(10):e1–e63.
   PubMed Web of Science ®Google Scholar
• Swan L. Systemic Right Ventricle. In: Swan L, Frogoudaki AA, editors. Heart failure in adult congenital heart disease. Cham: Springer International Publishing; 2018. p. 115–127.
   Google Scholar
• Winter MM, van der Plas MN, Bouma BJ, et al. Mechanisms for cardiac output augmentation in patients with a systemic right ventricle. Int J Cardiol. 2010 Aug 20 143(2):141–146.
   PubMed Web of Science ®Google Scholar
• Fratz S, Hager A, Busch R, et al. Patients after atrial switch operation for transposition of the great arteries can not increase stroke volume under dobutamine stress as opposed to patients with congenitally corrected transposition. Circ J. 2008 Jul;72(7):1130–1135.
   PubMed Web of Science ®Google Scholar
• Cuypers JA, Eindhoven JA, Slager MA, et al. The natural and unnatural history of the Mustard procedure: long-term outcome up to 40 years. Eur Heart J. 2014 Jul 1 35(25):1666–1674.
   PubMed Web of Science ®Google Scholar
• Dipchand AI, Honjo O, Alonso-Gonzalez R, et al. Heart transplant indications, considerations and outcomes in Fontan patients: age-related nuances, transplant listing and disease-specific indications. Can J Cardiol. 2022 Feb 28;38(7):1072–1085.
   PubMed Web of Science ®Google Scholar
• Rychik J, Atz AM, Celermajer DS, et al. Evaluation and management of the child and adult with fontan circulation: a scientific statement from the American Heart Association. Circulation (New York, NY). 2019;140(6): e234–e284
   Google Scholar
• Broda CR, Downing TE, John AS. Diagnosis and management of the adult patient with a failing Fontan circulation. Heart Fail Rev. 2020;25(4):633–646.
   PubMed Web of Science ®Google Scholar
• Shah KS, Xu H, Matsouaka RA, et al. Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes. J Am Coll Cardiol. 2017;70(20):2476–2486.
   PubMed Web of Science ®Google Scholar
• Redfield MM, Jacobsen SJ, Burnett JC Jr., et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003 Jan 8;289(2):194–202.
   PubMed Web of Science ®Google Scholar
• Egbe AC, Miranda WR, Pellikka PA, et al. Prevalence and prognostic implications of left ventricular systolic dysfunction in adults with congenital heart disease. J Am Coll Cardiol. 2022 Apr 12;79(14):1356–1365.
   PubMed Web of Science ®Google Scholar
• Wang F, Harel-Sterling L, Cohen S, et al. Heart failure risk predictions in adult patients with congenital heart disease: a systematic review. Heart. 2019 Nov;105(21):1661–1669.
   PubMed Web of Science ®Google Scholar
• Rahimi K, Bennett D, Conrad N, et al. Risk prediction in patients with heart failure. JACC: Heart Failure. 2014;2(5):440–446.
   PubMed Web of Science ®Google Scholar
• Wang F, Sterling LH, Liu A, et al. Risk of readmission after heart failure hospitalization in older adults with congenital heart disease. Int J Cardiol. 2020 Dec 1;320:70–76.
   PubMed Web of Science ®Google Scholar
• De Meester P, Budts W. Drug therapy in adult congenital heart disease heart failure. In: Swan L, Frogoudaki AA, editors. Heart failure in adult congenital heart disease. Cham: Springer International Publishing; 2018. p. 187–200.
   Google Scholar
• McDonagh TA, Metra M, Adamo M, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021;42(36):3599–3726.
   PubMed Web of Science ®Google Scholar
• Zaragoza-Macias E, Zaidi AN, Dendukuri N, et al. Medical Therapy for systemic right ventricles: a systematic review (part 1) for the 2018 aha/acc guideline for the management of adults with congenital heart disease: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2019 Apr 2;73(12):1564–1578.
   PubMed Web of Science ®Google Scholar
• Alonso-Gonzalez R, Massarella D, et al. Complex cyanotic congenital heart disease: the “Mixing” lesions. In: Fuster V, Narula J, Vaishnava P, editors. Fuster and hurst’s the heart, 15e. New York: NY McGraw-Hill Education; 2022. pp. 2032.
   Google Scholar
• Amedro P, Gavotto A, Abassi H, et al. Efficacy of phosphodiesterase type 5 inhibitors in univentricular congenital heart disease: the SV‐INHIBITION study design. ESC Heart Fail. 2020;7(2):747–756.
   PubMed Web of Science ®Google Scholar
• Flügge A-K, Wasmer K, Orwat S, et al. Cardiac resynchronization therapy in congenital heart disease: results from the German National Register for Congenital Heart Defects. Int J Cardiol. 2018;273:108–111.
   PubMed Web of Science ®Google Scholar
• Cazzoli I, Ernst S. Arrhythmia and Devices. In: Swan L, Frogoudaki AA, editors. Heart failure in adult congenital heart disease. Cham: Springer International Publishing; 2018. p. 201–222.
   Google Scholar
• Chubb H, Rosenthal DN, Almond CS, et al. Impact of cardiac resynchronization therapy on heart transplant-free survival in pediatric and congenital heart disease patients. Circ Arrhythm Electrophysiol. 2020 Apr;13(4):e007925.
   PubMed Web of Science ®Google Scholar
• Janousek J, Gebauer RA, Abdul-Khaliq H, et al. Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates. Heart. 2009 Jul;95(14):1165–1171.
   PubMed Web of Science ®Google Scholar
• Anjewierden S, Aziz PF. Resynchronization therapy for patients with congenital heart disease: are we ready for prime time? Curr Cardiol Rep. 2018 Jul 18; 20(9):75.
   PubMed Web of Science ®Google Scholar
• Inuzuka R, Diller GP, Borgia F, et al. Comprehensive use of cardiopulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium term. Circulation. 2012 Jan 17 125(2):250–259.
   PubMed Web of Science ®Google Scholar
• Baggen VJ, van den Bosch AE, Eindhoven JA, et al. Prognostic value of n-terminal pro-b-type natriuretic peptide, troponin-t, and growth-differentiation factor 15 in adult congenital heart disease. Circulation. 2017 Jan 17;135(3):264–279.
   PubMed Web of Science ®Google Scholar
• Westhoff-Bleck M, Podewski E, Tutarel O, et al. Prognostic value of NT-proBNP in patients with systemic morphological right ventricles: a single-centre experience. Int J Cardiol. 2013;169(6):433–438.
   PubMed Web of Science ®Google Scholar
• Baggen VJM, Venema E, Živná R, et al. Development and validation of a risk prediction model in patients with adult congenital heart disease. Int J Cardiol. 2019;276:87–92.
   PubMed Web of Science ®Google Scholar
• S-cmdp Y, Lmbc H, Vsmd C, et al. identifying high risk in adults with congenital heart disease and atrial arrhythmias. Am J Cardiol. 2011;108(5):723–728
   PubMed Web of Science ®Google Scholar
• Kempny A, Hjortshøj CS, Gu H, et al. Predictors of death in contemporary adult patients with eisenmenger syndrome: a multicenter study. Circulation (New York, NY). 2017;135(15): 1432–1440
   Google Scholar
• Lorts A, Conway J, Schweiger M, et al. ISHLT consensus statement for the selection and management of pediatric and congenital heart disease patients on ventricular assist devices endorsed by the American heart association. J Heart Lung Transplant. 2021 Aug;40(8):709–732.
   PubMed Web of Science ®Google Scholar
• Menachem JN, Burchill LJ. Transplantation and mechanical circulatory support in adult congenital heart disease-related advanced heart failure. In: Swan L, Frogoudaki AA, editors. Heart failure in adult congenital heart disease. Cham: Springer International Publishing; 2018. p. 223–239.
   Google Scholar
• Schweiger M, Lorts A, Conway J. Mechanical circulatory support challenges in pediatric and (adult) congenital heart disease. Curr Opin Organ Transplant. 2018;23(3):301–307.
   PubMed Web of Science ®Google Scholar
• Cedars A, Kutty S, Danford D, et al. Systemic ventricular assist device support in Fontan patients: a report by ACTION. J Heart Lung Transplant. 2021 May;40(5):368–376.
   PubMed Web of Science ®Google Scholar
• Bedzra EKS, Adachi I, Peng DM, et al. Systemic ventricular assist device support of the Fontan circulation yields promising outcomes: an analysis of the society of thoracic surgeons pedimacs and intermacs databases. J Thorac Cardiovasc Surg. 2021 Nov 27 164(2):353–364.
   PubMedGoogle Scholar
• Serfas JD, Patel PA, Krasuski RA. Heart transplantation and mechanical circulatory support in adults with congenital heart disease. Curr Cardiol Rep. 2018 Aug 9; 20(10):81
   PubMed Web of Science ®Google Scholar
• Maxwell BG, Wong JK, Sheikh AY, et al. Heart transplantation with or without prior mechanical circulatory support in adults with congenital heart disease. Eur J Cardiothorac Surg. 2014 May;45(5):842–846
   PubMed Web of Science ®Google Scholar
• Mehra MR, Canter CE, Hannan MM, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transplant. 2016 Jan;35(1):1–23.
   PubMed Web of Science ®Google Scholar
• Tmdms K, Diggs BSP, Kmdms W, et al. Impact of single-ventricle physiology on death after heart transplantation in adults with congenital heart disease. Ann Thorac Surg. 2012;94(4):1281–1288.
   PubMed Web of Science ®Google Scholar
• Irving C, Parry G, O’Sullivan J, et al. Cardiac transplantation in adults with congenital heart disease. Heart. 2010;96(15):1217–1222.
   PubMed Web of Science ®Google Scholar
• Greutmann M, Prêtre R, Furrer L, et al. Heart transplantation in adolescent and adult patients with congenital heart disease: a case-control study. Transplant Proc. 2009;41(9):3821–3826.
   PubMed Web of Science ®Google Scholar
• Chen JM, Davies RR, Mital SR, et al. Trends and outcomes in transplantation for complex congenital heart disease: 1984 to 2004. Ann Thorac Surg. 2004;78(4):1352–1361.
   PubMed Web of Science ®Google Scholar
• Marelli AJ, Ionescu-Ittu R, Mackie AS, et al. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation. 2014 Aug 26 130(9):749–756
   PubMed Web of Science ®Google Scholar
• D’Alto M, Romeo E, Argiento P, et al. Hemodynamics of patients developing pulmonary arterial hypertension after shunt closure. Int J Cardiol. 2013;168(4):3797–3801.
   PubMed Web of Science ®Google Scholar
• Yong G, Khairy P, De Guise P, et al. Pulmonary arterial hypertension in patients with transcatheter closure of secundum atrial septal defects: a longitudinal study. Circ Cardiovasc Interventions. 2009;2(5):455–462.
   PubMed Web of Science ®Google Scholar
• Humenberger M, Rosenhek R, Baumgartner H, et al. Benefit of atrial septal defect closure in adults: impact of age. Eur Heart J. 2011;32(5):553–560.
   PubMed Web of Science ®Google Scholar
• Escher A, Strauch C, Hubmann EJ, et al. A cavopulmonary assist device for long-term therapy of fontan patients. Semin Thorac Cardiovasc Surg. 2022;34(1):238–248.
   PubMed Web of Science ®Google Scholar